Thereby, the prime standard to confirm prostate cancer is a tissue biopsy, as the PSA screening tests appear to be clinically insignificant in the diagnosis of prostate cancer [24], and different guideline standards for PSA screening have resulted in over-testing and unnecessary biopsies have raised concerns in healthcare practice [5]. The gene discussed is KLK3; the disease is Familial prostate cancer.